Palisade Bio (FRA:7NS0) Net Issuance of Preferred Stock : €0.00 Mil (TTM As of Mar. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Palisade Bio Net Issuance of Preferred Stock?

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares.

Palisade Bio's net issuance of preferred for the three months ended in Mar. 2024 was €0.00 Mil. The number is 0, which means that Palisade Bio has paid equal amouunt of cash to buy back preferred shares to the amount it received for issuing preferred shares quarterly.

Palisade Bio's net issuance of preferred for the trailing twelve months (TTM) ended in Mar. 2024 was €0.00 Mil.

Palisade Bio Net Issuance of Preferred Stock Historical Data

The historical data trend for Palisade Bio's Net Issuance of Preferred Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Palisade Bio Net Issuance of Preferred Stock Chart

Palisade Bio Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Net Issuance of Preferred Stock

17.61

Palisade Bio Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Net Issuance of Preferred Stock	Get a 7-Day Free Trial											-	-	-	-	-

Palisade Bio Net Issuance of Preferred Stock Calculation

A company may raise cash from issuing new preferred shares. It can also use cash to buy back preferred shares. If this number is positive, it means that the company has received more cash from issuing preferred shares than it has paid to buy back preferred shares. If this number is negative, it means that company has paid more cash to buy back preferred shares than it has received for issuing preferred shares.

Net Issuance of Preferred Stock for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.00 Mil.

Palisade Bio Net Issuance of Preferred Stock Related Terms

Thank you for viewing the detailed overview of Palisade Bio's Net Issuance of Preferred Stock provided by GuruFocus.com. Please click on the following links to see related term pages.

Palisade Bio (FRA:7NS0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Palisade Bio Inc (FRA:7NS0) » Definitions » Net Issuance of Preferred Stock

Comparable Companies

Traded in Other Exchanges

PALI:USA

Address

5800 Armada Drive, Suite 2A, Carlsbad, CA, USA, 92008

Website

https://www.palisadebio.com

Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery.

Palisade Bio (FRA:7NS0) Headlines

No Headlines